INJECTION SITE HAEMORRHAGE

Adverse reaction reported in 38,874 FDA reports across 12 drugs.

38,874
Total Reports
12
Drugs Involved
Adalimumab
Most Reported Drug

Drugs Associated with INJECTION SITE HAEMORRHAGE

Drugs where "INJECTION SITE HAEMORRHAGE" was reported as an adverse event.

# Drug Reports % of Total
1 Adalimumab 16,168
41.6%
2 Tirzepatide 5,035
13.0%
3 Teriparatide 4,498
11.6%
4 Evolocumab 3,893
10.0%
5 Dulaglutide 3,145
8.1%
6 Exenatide 1,809
4.7%
7 Galcanezumab-Gnlm 1,547
4.0%
8 Somatropin 1,082
2.8%
9 Alirocumab 685
1.8%
10 Ixekizumab 600
1.5%
11 Peginterferon Beta-1a 265
0.7%
12 Nemolizumab-Ilto 147
0.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused injection site haemorrhage. Always consult your healthcare provider.